In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the health-care system in this country.

Our bipartisan efforts on organ transplants--thank you very much, Senator Grassley--have really paid off.

Every drug should have a price that is available for all to see and creates equity.

It undermines the negotiation entirely.

Taxpayers, seniors facing a 2,000-percent markup.

I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.

Your bill with Senator Grassley should make it more difficult for PBMs to hide profits from regulators.

Every drug should have a price that is available for all to see and creates equity.

That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers and patients aren't getting a raw deal.

The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.

What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?

Civica cannot get the big three PBMs to cover the drug.

That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers and patients aren't getting a raw deal.

The problem is that the person negotiating on behalf of the patient should not be getting paid by the other side.

Civica cannot get the big three PBMs to cover the drug.

The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.

Your bill with Senator Grassley should make it more difficult for PBMs to hide profits from regulators.

I'm proud to say that this is a hearing with strong bipartisan interest, and Senator Crapo and I have agreed to take on this issue together.

Taxpayers, seniors facing a 2,000-percent markup.

I am leading a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would crack down on PBM's opaque rebate practices.

It undermines the negotiation entirely.

That is why I previously cosponsored something called Creating Transparency to Have Drug Rebates Unlocked.

The Pharmacy Benefit Manager Transparency Act of 2023 would make material improvements to the transparency of the U.S. health-care system.

We want to make this a bipartisan effort in this committee.

People care a whole lot about this matter of getting mugged at the pharmacy counter.